Soluble adhesion molecules and C-reactive protein in the progression of silent cerebral infarction in patients with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 55, Issue 4, 2006, Pages 461-466

  Kawamura, Takahiko ^a   Umemura, Toshitaka ^b   Kanai, Akio ^a   Nagashima, Masahito ^a   Nakamura, Nobuhisa ^a   Uno, Tomoko ^a   Nakayama, Mikihiro ^a   Sano, Takahisa ^a   Hamada, Yoji ^c   Nakamura, Jiro ^c   Hotta, Nigishi ^a  

^a CHUBU ROSAI HOSPITAL   (Japan)

^b Kasugai City Hospital   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR ADHESION PROTEIN 1;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; BRAIN INFARCTION; CONTROLLED STUDY; DIABETES CONTROL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; STROKE; VASCULAR DISEASE;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CELL ADHESION MOLECULES; CEREBRAL INFARCTION; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; SOLUBILITY;

EID: 33644959650     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2005.10.007     Document Type: Article

References (37)

1. J.A. Beckman, M.A. Creager, and P. Libby Diabetes and atherosclerosis. Epidemiology, pathophysiology, and management JAMA 287 2002 2570 2581
2. B.N. Mankovsky, and D. Ziegler Stroke in patients with diabetes mellitus Diabetes Metab Res Rev 20 2004 268 287
3. Y. Tanizaki, Y. Kiyohara, I. Kato, H. Iwamoto, K. Nakayama, and N. Shinohara Incidence and risk factors for subtype of cerebral infarction in general population. The Hisayama Study Stroke 31 2000 2616 2622
4. A. Aruz, L. Murillo, C. Cantu, F. Barinagarrementeria, and J. Higuera Prospective study of single and multiple lacunar infarcts using magnetic resonance imaging. Risk factors, recurrence, and outcome in 175 consecutive cases Stroke 34 2003 2453 2458
5. I.A. Awad, R.F. Spetzler, J.A. Hodak, C.A. Awad, and R. Carey Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors Stroke 17 1986 1084 1089
6. C.S. Kase, P.A. Wolf, E.H. Chodosh, H.B. Zacker, M. Kelly-Hayes, and W.B. Kannel Prevalence of silent stroke in patients presenting with initial stroke: the Framingham study Stroke 20 1989 850 852
7. S. Kobayashi, K. Okada, H. Koide, H. Bokura, and S. Yamaguchi Subcortical silent brain infarction as a risk factor for clinical stroke Stroke 28 1997 1932 1939
8. C. Bernick, L. Kuller, C. Dulberg, W.T. Longstreth Jr, T. Manolio, and N. Beauchamp Silent MRI infarcts and the risk of future stroke. The cardiovascular health study Neurology 57 2001 1222 1229
9. S.E. Vermeer, T. dem Heijer, P.J. Koudstaal, M. Oudkerk, A. Hofman, and M.B. Breteler Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study Stroke 34 2003 392 396
10. K. Eguchi, K. Kario, and K. Shimada Greater impact of coexistence of hypertension and diabetes on silent cerebral infarcts Stroke 34 2003 2471 2474
11. R. Ross The pathogenesis of atherosclerosis-an update N Engl J Med 314 1986 488 500
12. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and others of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
13. J.D. Curb, R.D. Abbott, B.L. Rodriguez, P. Sakkinen, J.S. Popper, and K. Yano C-reactive protein and future risk of thromboembolic stroke in healthy men Circulation 107 2003 2016 2020
14. D.T. Price, and J. Loscalzo Cellular adhesion molecules and atherogenesis Am J Med 107 1999 85 97
15. S.-J. Hwang, M. Ballantyne, R. Sharrett, L.C. Smith, C.E. Davis, and A.M. Gotto Jr Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. The atherosclerosis risk in communities (ARIC) study Circulation 96 1997 4219 4225
16. S. Blankenberg, S. Barbaux, and L. Tiret Adhesion molecules and atherosclerosis Atherosclerosis 170 2003 191 203
17. P.M. Ridker, C.H. Hennekens, B. Roitman-Johnson, M.J. Stampfer, and J. Allen Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy Lancet 351 1998 88 92
18. S. Blankenberg, H.J. Rupprecht, C. Bickel, D. Peetz, G. Hafner, and L. Tiret Circulating cell adhesion molecules and death in patients with coronary artery disease Circulation 104 2001 1336 1342
19. D. Tanne, M. Haim, V. Boyko, U. Goldbourt, T. Reshef, and S. Matetzky Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke. A nested case-control study from the bezafibrate infarction prevention (BIP) study cohort Stroke 33 2002 2182 2186
20. A.J.H. Gearing, and W. Newman Circulating adhesion molecules in disease Immunol Today 14 1993 506 512
21. M. Steiner, K.M. Reinhardt, B. Krammer, B. Ernst, and A.D. Blann Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control Thromb Haemost 72 1994 979 984
22. T. Kawamura, T. Umemura, A. Kanai, T. Uno, H. Matsumae, and T. Sano The incidence and characteristics of silent cerebral infarction in elderly diabetic patients: association with serum-soluble adhesion molecules Diabetologia 41 1998 911 917
23. N. Takeuchi, T. Kawamura, A. Kanai, N. Nakamura, T. Uno, and T. Hara The effect of cigarette smoking on soluble adhesion molecules in middle-aged patients with type 2 diabetes mellitus Diabet Med 19 2002 57 64
24. M. Otsuki, K. Hashimoto, Y. Morimoto, T. Kishimoto, and S. Kasayama Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients Diabetes 46 1997 2096 2101
25. K. Matsumoto, Y. Sera, Y. Ueki, G. Inukai, E. Niiro, and S. Miyake Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy Diabet Med 19 2002 822 826
26. K. Fassbender, T. Bertsch, O. Mielke, F. Muhlhauser, and M. Hennerici Adhesion molecules in cerebrovascular disease. Evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease Stroke 30 1999 1647 1650
27. F.C. Barone, and G.Z. Feuerstein Inflammatory mediators and stroke: new opportunities for novel therapeutics J Cereb Blood Flow Metab 19 1999 819 834
28. C.J.M. Frijins, and L.J. Kappelle Inflammatory cell adhesion molecules in ischemic cerebrovascular disease Stroke 33 2002 2115 2122
29. A. Jager, W.M. van Hinsbergh, P.J. Kostense, J.J. Emeis, G. Nijpels, and J.M. Deker Increased levels of soluble vascular cell adhesion molecules 1 are associated with risk of cardiovascular mortality in type 2 diabetes. The Hoorn Study Diabetes 49 2000 485 491
30. T.B. Ledue, D.L. Weiner, J.D. Sipe, S.E. Poulin, M.F. Collins, and N. Rifai Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum Ann Clin Biochem 35 1998 745 753
31. A. Hassan, B.J. Hunt, M. O'Sullivan, K. Parmar, J.M. Bamford, and D. Briley Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis Brain 126 2003 424 432
32. D.C. Hess, W. Zhao, J. Carroll, M. McEachin, and K. Buchanan Increased expression of ICAM-1 during reoxygenation in brain endothelial cells Stroke 25 1994 1463 1468
33. Y. Matsuo, Y. Yamasaki, and K. Kogure Inflammatory reaction after brain damage and prospective therapy against damage impending cerebral infarction Keio J Med 45 1996 270 274
34. A. Becker, V.M.M. van Hisbergh, A. Jager, P.J. Kostense, J.M. Dekker, and G. Nijpels Why is soluble intercellular adhesion molecule-1 related to cardiovascular mortality? Eur J Clin Invest 32 2002 1 8
35. D.J. Rader Inflammatory markers of coronary risk N Engl J Med 343 2000 1179 1182
36. C. Ferri, G. Desideri, R. Baldoncini, C. Bellini, C. De Angelis, and C. Mazzocchi Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities Diabetes 47 1996 660 667
37. H. Nawai, N.S. Osman, R. Annuar, B.A.K. Khalid, and K. Yusoff Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atrovastatin Atherosclerosis 169 2003 283 291